The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccineesJulie Van Coillie, Tamás Pongrácz, Johann Rahmöller et al.|EBioMedicine|2022Cited by 39
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccinesJulie Van Coillie, Cinzia Bassoli, Tamás Pongrácz et al.|iScience|2023Cited by 25
Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapyPim Bouwmans, Debbie van Baarle, Fréderike J. Bemelman et al.|Clinical Kidney Journal|2022Cited by 20
Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire studySophie C. Frölke, W. M. T. Janssen, Pim Bouwmans et al.|EClinicalMedicine|2023Cited by 7